Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gangnam Severance Hospital
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Investigators conducted a retrospective study using data from 857 patients with pancreatic cancer enrolled in two hospitals in the Republic of Korea (179 from Gangnam Severance Hospital and 678 from Seoul National University Hospital) from January 5, 2010 to December 31, 2019.
You may not be if
Investigators excluded patients without information about preoperative tumor marker levels (n = 45), those who received neoadjuvant (n = 169), those with preoperative CA19-9 levels \< 9.0 \[Lewis antibody-negative patients\] (n = 98), those with missing covariates (n = 3) and R2 resection (n = 6).
Clareo Health | New Predictive Marker for Pancreatic Cancer Using CA19-9 and Fecal Elastase
